Application of NGS Technique in Precise Diagnosis of Infectious Diseases
Launched by HUASHAN HOSPITAL · Jul 25, 2017
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients are highly suspected of fever of unknown origin
- • Patients are highly suspected of bloodstream infection
- • Patients are highly suspected of respiratory infections
- • Patients are highly suspected of central nervous system infection
- Exclusion Criteria:
- • Patients diagnosed as non-infectious diseases such as cancer and autoimmune diseases;
About Huashan Hospital
Huashan Hospital, affiliated with Fudan University in Shanghai, is a leading medical institution renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, Huashan Hospital leverages its extensive expertise in various medical disciplines to advance the development of new therapies and treatment modalities. The hospital's state-of-the-art facilities and multidisciplinary teams facilitate rigorous clinical investigations, ensuring adherence to ethical standards and regulatory compliance. With a focus on improving patient outcomes, Huashan Hospital actively collaborates with academic and industry partners to drive forward-thinking research initiatives that address critical healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials